Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Retrospective analyses of cancer trials or existing clinical databases: potential for highly clinically relevant hypothesis generation.

Markman M.

Oncology. 2012;83(6):329-30. doi: 10.1159/000342174. Epub 2012 Sep 18. No abstract available.

PMID:
23007076
3.

Therapeutic studies.

Rubinstein LV.

Hematol Oncol Clin North Am. 2000 Aug;14(4):849-76, ix. Review.

PMID:
10949777
4.

Clinical cancer research 2001: new agents and therapies.

Verweij J, de Vries EG.

Drug Resist Updat. 2001 Aug;4(4):217-23. Review. No abstract available.

PMID:
11991676
5.

Stat bite: Treatment trials in the PDQ clinical trials database, by phase.

[No authors listed]

J Natl Cancer Inst. 2004 Sep 15;96(18):1355. No abstract available.

PMID:
15367566
6.

[The revision of Guidelines for Clinical Evaluation Methods of Anti-Cancer Drugs in Japan].

Andoh M, Fujiwara Y, Shimada Y.

Gan To Kagaku Ryoho. 2006 Jul;33(7):1015-9. Japanese.

PMID:
16878363
7.

[Recent proposals for early stage clinical trials of cancer].

Ohashi Y.

Gan To Kagaku Ryoho. 1994 Oct;21 Suppl 3:292-4. Review. Japanese.

PMID:
7986106
8.

Research outcomes and recommendations for the assessment of progression in cancer clinical trials.

Bushnell W, Stone A.

J Biopharm Stat. 2013;23(5):949-50. doi: 10.1080/10543406.2013.813718. No abstract available.

PMID:
23957508
9.

The next generation: new chemotherapy agents for the 1990s.

Galassi A.

Semin Oncol Nurs. 1992 May;8(2):83-94. Review.

PMID:
1621007
10.

Trend toward noninferiority trials may mean more difficult interpretation of trial results.

Tuma RS.

J Natl Cancer Inst. 2007 Dec 5;99(23):1746-8. Epub 2007 Nov 27. No abstract available.

PMID:
18042926
11.

Cancer clinical trials. A rational basis for use of historical controls.

Gehan EA, Freireich EJ.

Semin Oncol. 1981 Dec;8(4):430-6. No abstract available.

PMID:
7323815
12.

On the biotech pharm, a race to harvest new cancer cures.

Roush W.

Science. 1997 Nov 7;278(5340):1039-40. No abstract available.

PMID:
9381202
13.

Global cancer event--SMi conference. Clinical Trials in Cancer.

Collins T.

IDrugs. 2004 Aug;7(8):711-3. No abstract available.

PMID:
15334299
14.

Overall survival: patient outcome, therapeutic objective, clinical trial end point, or public health measure?

Saad ED, Buyse M.

J Clin Oncol. 2012 May 20;30(15):1750-4. doi: 10.1200/JCO.2011.38.6359. Epub 2012 Mar 5. No abstract available.

PMID:
22393092
15.

Clinical drug trials.

Edgar L.

Can Nurse. 1983 Feb;79(2):24-5. No abstract available.

PMID:
6549907
16.
17.

The quandary of experimental chemotherapy.

Modan B.

Med Oncol Tumor Pharmacother. 1992;9(3):111-2. No abstract available.

PMID:
1341322
18.

The role of overviews in cancer therapeutics.

Simon R.

Stat Med. 1987 Apr-May;6(3):389-96.

PMID:
3616291
19.

NCI's cancer therapy evaluation program: a commitment to treatment trials.

Abrams JS, Murgo A, Christian MC.

Cancer Treat Res. 2007;132:31-50. Review. No abstract available.

PMID:
17305016
20.

Adaptive design may hasten clinical trials.

Schmidt C.

J Natl Cancer Inst. 2007 Jan 17;99(2):108-9. No abstract available.

PMID:
17227993

Supplemental Content

Support Center